It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Delirium develops through a multifactorial process and include multiple subtypes with different pathological factors. To refine the treatment and care for delirium, a more detailed examination of these subtypes is needed. Therefore, this study aimed to explore the factors affecting delirium in cases in which hallucinations are conspicuous. In total, 602 delirium cases referred to the psychiatry department at a general hospital between May 2015 and August 2020 were enrolled. The Delirium Rating Scale-revised-98 was used to assess perceptual disturbances and hallucinations in patients with delirium. Multiple regression analysis was applied to determine whether individual factors were associated with the hallucinations. A total of 156 patients with delirium (25.9%) experienced hallucinations, with visual hallucinations being the most common subtype. Alcohol drinking (p < 0.0005), benzodiazepine withdrawal (p = 0.004), and the use of angiotensin II receptor blockers (p = 0.007) or dopamine receptor agonists (p = 0.014) were found to be significantly associated with hallucinations in patients with delirium. The four factors detected in this study could all be reversible contributing factors derived from the use of or withdrawal from exogenous substances.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Nagoya Ekisaikai Hospital, Department of Psychiatry, Nagoya-shi, Japan (GRID:grid.416417.1) (ISNI:0000 0004 0569 6780); Nagoya University Graduate School of Medicine, Department of Psychiatry, Nagoya-shi, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X)
2 Nagoya University Graduate School of Medicine, Department of Psychiatry, Nagoya-shi, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X); Nagoya University Graduate School of Medicine, Department of Psychobiology, Nagoya-shi, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X)
3 Nagoya Ekisaikai Hospital, Department of Psychiatry, Nagoya-shi, Japan (GRID:grid.416417.1) (ISNI:0000 0004 0569 6780)
4 Nagoya University Graduate School of Medicine, Department of Psychiatry, Nagoya-shi, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X)